13F filer · CIK 310158
Merck & Co., Inc.
RAHWAY, NJ · filing since Q4 2024 · last filing Aug 7, 2026
Reported value
$526.4M
+$177.0M vs prior
Positions
13
New / sold out
3 / 4
Added / reduced
0 / 0
Turnover
5.8%
buys $25.6M · sells $33.3M
Top-10 weight
99.8%
Biggest buys vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| New | ENTRADA THERAPEUTICS INC | +1,739,768 | – | +$12.8M |
| New | SUTRO BIOPHARMA INC | +272,351 | – | +$9.0M |
| New | EVAXION BIOTECH A/S | +1,214,126 | – | +$3.8M |
Biggest sells vs Q1 2026
| Change | Security | Shares change | Change % | Est. trade value |
|---|---|---|---|---|
| Sold out | ENTRADA THERAPEUTICS INC | -1,739,768 | -100.0% | $-22.0M |
| Sold out | SUTRO BIOPHARMA INC | -272,351 | -100.0% | $-6.8M |
| Sold out | EVAXION BIOTECH A/S | -1,214,126 | -100.0% | $-4.5M |
| Sold out | CARISMA THERAPEUTICS INC | -1,473,240 | -100.0% | $-47.9K |
Estimated trade value = change in shares × this quarter's implied price. 13F filings show quarter-end positions, not individual trades.
Reported value by quarter
Holdings · Q2 2026
| # | Security | Shares | Value | Weight |
|---|---|---|---|---|
| 1 | PERSONALIS INCCOM | 14,044,943 | $188.2M | 35.75% |
| 2 | MODERNA INCCOM | 2,308,190 | $161.6M | 30.71% |
| 3 | KYMERA THERAPEUTICS INCCOM | 772,165 | $88.5M | 16.82% |
| 4 | AKTIS ONCOLOGY INCCOM | 952,844 | $30.7M | 5.83% |
| 5 | EIKON THERAPEUTICS INCCOM | 1,666,666 | $21.7M | 4.13% |
| 6 | ENTRADA THERAPEUTICS INCCOM | 1,739,768 | $12.8M | 2.43% |
| 7 | SUTRO BIOPHARMA INCCOM | 272,351 | $9.0M | 1.72% |
| 8 | ALECTOR INCCOM | 3,545,719 | $7.1M | 1.35% |
| 9 | EVAXION BIOTECH A/SSPONSORED ADS | 1,214,126 | $3.8M | 0.71% |
| 10 | VIRIDIAN THERAPEUTICS INCCOM | 93,414 | $1.7M | 0.33% |
3 more rows. Subscribe for $29/month to see every row, download the data and use the API.